Proud Sponsor of the Organization of Women in International Trade - Badge

Antitrust Lawyer Blog

FTC Withdraws Nine-Year Policy Statement on Monetary Equitable Remedies in Competition Cases
Doyle, Barlow & Mazard PLLC

On July 31, 2012, the Federal Trade Commission (Commission) issued a statement withdrawing the Commission's nine-year-old Policy Statement on Monetary Equitable Remedies in Competition Cases (Policy Statement). The statement's withdrawal was approved on a 4-1 split vote, with Commissioner Maureen K. Ohlhausen casting the lone no vote and issuing a dissenting opinion. The 2003 Policy…

Continue reading ›
Third Circuit Supports FTC On “Pay for Delay”
Doyle, Barlow & Mazard PLLC

On July 16th, the Third Circuit Court of Appeals ruled that pharmaceutical “pay-for-delay” settlements whereby cash is paid from a patent holding company to a generic manufacturer that agrees not to enter a market as prima facie evidence of an antitrust violation. The Third Circuit rejects the more lenient standard adopted by the other Circuit…

Continue reading ›
Seventh Circuit Sets Forth Elements for a Claim to Meet FTAIA
Doyle, Barlow & Mazard PLLC

On June 27th, 2012, the 7th Circuit established elements extending the reach of United States antitrust law to certain cases where foreign companies engage in anticompetitive conduct outside the United States. (Minn-Chem, Inc., et al., v. Agrium Inc., No. 10-1712, slip op. (7th Cir. June 27, 2012)). Background In Minn-Chem, indirect U.S. potash purchasers alleged…

Continue reading ›
Executive Agrees to Go to Jail for Submitting Falsified Documents to the Antitrust Agencies During the Merger Review Process
Doyle, Barlow & Mazard PLLC

On May 3, 2012, the Antitrust Division of the Department of Justice (“DOJ”) announced that an executive of Hyosung Corporation, an affiliate of Nautilus Hyosung Holdings Inc. (“Nautilus”), agreed to plead guilty and serve five months in prison in the United States for obstruction of justice charges in connection with the antitrust agencies' merger investigation…

Continue reading ›
FTC Closes Investigation of Express Script’s Proposed Acquisition of Medco
Doyle, Barlow & Mazard PLLC

On April 2, 2012, the Federal Trade Commission (“FTC”) closed its investigation of Express Scripts, Inc.'s (“Express Scripts”) proposed acquisition of pharmacy benefits manager (“PBM”), Medco Health Solutions, Inc. (“Medco”) Express Scripts consummated its acquisition of Medco on the same day. Background On July 20, 2011, Express Scripts entered into an agreement to acquire Medco…

Continue reading ›
Humana Settles With DOJ Regarding Arcadian
Doyle, Barlow & Mazard PLLC

On March 27, 2012, the DOJ announced it would require Humana, a leading health insurer in the United States with 2010 revenues of approximately $33.6 billion, and Arcadian, which had approximately 62,000 MA members in 15 states and 2010 revenues of $622 million, to divest assets relating to Arcadian’s MA business in parts of five…

Continue reading ›
DOJ Requires Divestitures Allowing International Paper to Acquire Temple-Inland
Doyle, Barlow & Mazard PLLC

On February 10, 2012, the Department of Justice (“Department”) entered into a settlement that allows International Paper to acquire Temple-Inland. The settlement agreement requires International Paper and Temple-Inland Inc. to divest three containerboard mills in order to proceed with their $4.3 billion merger. The Department said that the merger, as originally proposed, would have substantially…

Continue reading ›
FTC to Revise Investigatory Rules, Attorney Disciplinary Rules
Doyle, Barlow & Mazard PLLC

On January 13, 2012, the FTC issued proposed amendments to Parts 2 and 4 of its Rules of Practice (“Rules”). Written comments must be received by March 23, 2012. The FTC first raised the need to reform Part 2 citing a substantial risk of delay and mistakes in the FTC’s discovery process based on the…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.